Crinetics Pharmaceuticals (CRNX)

• Market cap: $4.07B
• 1 day: -0.26%
• 5 days: 1.47%
• 1 month: 1.06%
• 3 months: 45.77%
• 6 months: 38.61%
• Year to date: -16.78%
• 1 year: -22.24%
• 5 years: 220.15%
• 10 years: 75.03%
• Sector: Healthcare
• Industry: Biotechnology

About: Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Employees: 437